Broadwood opposes Alcon's STAAR Surgical acquisition bid
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Broadwood Partners Condemns Alcon’s Fallacious Attacks on STAAR Surgical and Its Prospects
November 4, 2025 11:52 AM ESTReminds STAARs Board That It Does Not Need Alcons Permission to Remain Independent or Run a Proper Strategic Alternatives Process
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (Broadwood or we) today commented on the investor presentation issued by Alcon Inc. (Alcon) (NYSE: ALC) regarding its proposed acquisition of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAARs outstanding common stock, continues to urge its fellow shareholders to vote on its GREEN Proxy... More



